Product Information
GS DUAL ACTION PAIN 250-125 MG is a generic product labeled by L. Perrigo Company, priced at $0.0899 per EA under NDC 00113530068. Its NADAC has been published 119 times since Mar 20, 2024.
Strength
250; 125 mg/1; mg/1
Manufacturer
L. Perrigo CompanyNDC
00113530068
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA214836On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for GS DUAL ACTION PAIN 250-125 MG has been published 119 times since Mar 20, 2024, and over the history we have for it it has risen 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0899 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.1086 |
| 52-week low | $0.0839 |
| Median price | $0.0892 |
| Average price | $0.0856 |
| Largest weekly change | +15.2% (Jul 17, 2024) |
| Weeks tracked | 119 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GS DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for GS DUAL ACTION PAIN 250-125 MG, manufactured by L. Perrigo Company, is $0.0899 per EA (NDC 00113530068), effective Jun 24, 2026.
How has the price of GS DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for GS DUAL ACTION PAIN 250-125 MG has risen 42.6%. It has been tracked across 119 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for GS DUAL ACTION PAIN 250-125 MG?
Since Mar 20, 2024, the NADAC for GS DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0892 per EA.
Are there cheaper alternatives to GS DUAL ACTION PAIN 250-125 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as GS DUAL ACTION PAIN 250-125 MG, but none are currently priced below it.
Who manufactures GS DUAL ACTION PAIN 250-125 MG?
GS DUAL ACTION PAIN 250-125 MG (NDC 00113530068) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.
Related Drugs
Same classification